Overview of Novartis/Sunovi Sunovi is a brand-name prescription medication that is manufactured by Novartis, a leading pharmaceutical company. It is mainly used to treat certain types of multiple sclerosis (MS), which is a chronic autoimmune disease that affects the central nervous system. Sunovi is a type of immunomodulator that reduces the frequency of relapse and delays the progression of physical disability in people with MS. It is available in two forms: an oral capsule and an oral solution. Uses of Sunovi Sunovi is primarily used to treat MS, a neurological condition that affects the brain and spinal cord. The medication works by targeting certain immune cells that attack the myelin sheath, which is a protective covering that surrounds the nerve fibers. By reducing the inflammation and damage to the myelin sheath, Sunovi can help improve the symptoms of MS and prevent further disability. It is most effective in treating relapsing-remitting MS, which is the most common type of MS that involves periods of symptom flare-up followed by remission. Dosage of Sunovi The dosage of Sunovi depends on several factors, such as the patient's age, weight, medical condition, and response to treatment. The recommended starting dose is one 12.5-mg capsule or one 2.5-mL solution taken once daily. After seven days, the dose is increased to two 12.5-mg capsules or two 2.5-mL solutions taken once daily. The maximum recommended dose is two 12.5-mg capsules or two 2.5-mL solutions taken once daily. Sunovi can be taken with or without food. Side Effects of Sunovi Like all medications, Sunovi may cause side effects, although not all patients experience them. The most common side effects of Sunovi include diarrhea, nausea, headache, stomach pain, fatigue, and abnormal liver function tests. Other potential side effects include infections, allergic reactions, liver injury, and liver failure. Patients should contact their healthcare provider if they experience any of these side effects or any other unusual symptoms. Interactions of Sunovi Sunovi may interact with other medications, vitamins, or supplements a patient is taking. Therefore, it is important to inform the healthcare provider about all the medications the patient is taking, including prescription, over-the-counter, and herbal medicines. Sunovi may interact with medications that affect the liver, such as amiodarone, carbamazepine, phenytoin, rifampin, and St. John's wort. It may also interact with medications that suppress the immune system, such as cyclosporine and tacrolimus. Generic of Sunovi Sunovi is not available in a generic form as of 2021. However, a generic version of the medication may become available in the future. The generic name of Sunovi is siponimod. Demographic of Sunovi Sunovi is approved for use in adults with relapsing forms of MS, including relapsing-remitting MS and active secondary progressive MS. The medication is not recommended for use in children or pregnant women. It is important to inform the healthcare provider about any medical conditions the patient has, including kidney disease, liver disease, infections, and allergies. Sunovi may not be suitable for patients with certain medical conditions or who are taking certain medications. In conclusion, Sunovi is a prescription medication manufactured by Novartis that is primarily used to treat relapsing forms of MS. It is available in two forms: an oral capsule and an oral solution. Sunovi works by targeting the immune cells that attack the myelin sheath, thereby reducing the inflammation and progression of MS. The dosage of Sunovi depends on several factors, and it may cause side effects or interact with other medications. Sunovi is not available in a generic form, and it is not recommended for use in children or pregnant women. Patients should inform their healthcare provider about any medical conditions or medications they are taking before starting Sunovi.